Mouse psychosocial stress reduces motivation and cognitive function in operant reward tests: A model for reward pathology with effects of agomelatine

Giorgio Bergamini, Flurin Cathomas, Sandra Auer, Hannes Sigrist, Erich Seifritz, Michael Patterson, Cecilia Gabriel, Christopher R Pryce

    Research output: Contribution to journalArticlepeer-review

    276 Downloads (Pure)

    Abstract

    A major domain of depression is decreased motivation for reward. Translational automated tests can be applied in humans and animals to study operant reward behaviour, aetio-pathophysiology underlying deficits therein, and effects of antidepressant treatment. Three inter-related experiments were conducted to investigate depression-relevant effects of chronic psychosocial stress on operant behaviour in mice. (A) Non-manipulated mice were trained on a complex reversal learning (CRL) test with sucrose reinforcement; relative to vehicle (VEH), acute antidepressant agomelatine (AGO, 25mg/kg p.o.) increased reversals. (B) Mice underwent chronic social defeat (CSD) or control handling (CON) on days 1-15, and were administered AGO or VEH on days 10-22. In a progressive ratio schedule motivation test for sucrose on day 15, CSD mice made fewer responses; AGO tended to reverse this effect. In a CRL test on day 22, CSD mice completed fewer reversals; AGO tended to increase reversals in CSD mice associated with an adaptive increase in perseveration. (C) Mice with continuous operant access to water and saccharin solution in the home cage were exposed to CSD or CON; CSD mice made fewer responses for saccharin and water and drank less saccharin in the active period, and drank more water in the inactive period. In a separate CSD cohort, repeated AGO was without effect on these home cage operant and consummatory changes. Overall, this study demonstrates that psychosocial stress in mice leads to depression-relevant decreases in motivation and cognition in operant reward tests; partial reversal of these deficits by AGO provides evidence for predictive validity.


    © 2016, Elsevier B.V. and ECNP. The attached document (embargoed until 13/07/2017) is an author produced version of a paper published in European Neuropsychopharmacology, uploaded in accordance with the publisher’s self- archiving policy. The final published version (version of record) is available online at https://doi.org/10.1016/j.euroneuro.2016.06.009. Some minor differences between this version and the final published version may remain. We suggest you refer to the final published version should you wish to cite from it.

    Original languageEnglish
    Pages (from-to)1448-64
    Number of pages17
    JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
    Volume26
    Issue number9
    Early online date13 Jul 2016
    DOIs
    Publication statusPublished - 26 Sept 2016

    Cite this